Literature DB >> 25199882

A giant renal angiomyolipoma (AML) in a patient with septo-optic dysplasia (SOD).

Marcin Cichocki, Marek Sosnowski, Zbigniew Jablonowski.   

Abstract

Angiomyolipoma (AML) is a rare benign renal tumor occurring in about 0.3 to 3% of the general population. Most frequently it takes the form of small single tumors occurring sporadically or accompanying tuberous sclerosis (Bourneville-Pringle disease). In some cases the tumor may reach a very large size and be a cause of various serious complications. This case description concerns a 26-year-old female patient, suffering from hypopituitarism, hypothyroidism and binocular blindness during the course of septo-optic dysplasia, in whom a giant, left renal AML was diagnosed and treated surgically. According to the authors' knowledge this was the first reported case of a huge size AML in a patient with de Morsier syndrome.

Entities:  

Mesh:

Year:  2014        PMID: 25199882      PMCID: PMC4172948          DOI: 10.1186/s40001-014-0046-8

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


Background

Angiomyolipoma (AML) is a rare benign renal tumor histologically containing elements of smooth muscle, adipose tissue and blood vessels in various proportions. It occurs in 0.3 to 3% of the general population, four-fold more frequently in women and the peak of incidence falls between the 30th and 50th years of life [1]. Most frequently (80%) these are small, singular tumors which occur unilaterally and occasionally. In the remaining cases they coexist with tuberous sclerosis (Bourneville-Pringle disease) and they may be bilateral and multiple and achieve significant sizes [2,3]. A tumor which is bigger than 10 cm and affects a whole organ is considered a ‘giant’ AML [4]. Septo-optic dysplasia (de Morsier syndrome) is a very rare syndrome of congenital defects consisting of optic nerve hypoplasia, hypopituitarism, and agenesis of the septum pellucidum [5,6].

Case presentation

The patient, a 26-year-old woman with a diagnosis of hypopituitarism, hypothyroidism and binocular blindness in the course of septo-ocular dysplasia was admitted to the Clinic of Urology because of a large tumor of the left kidney. The patient was 139 cm tall, weighed 52 kg and her BMI amounted to 27 kg/m2. Her blood pressure was 120/70 mmHg, heart rate 70/minute, creatinine levels 66 μmol/l, and her electrolytes, blood count and urinalysis were normal. The lesion had been diagnosed incidentally in another medical centre during investigation of persistent stomach ache with a suspicion of pyelonephritis. During case examination a perceptible mobile pathological resistance was reported on the left side of the stomach from the costal arch up to the iliac fossa. On abdominal ultrasonography (USG) examination, a large, intra-abdominal and left flank heterogeneous tumor with dimensions 170 × 78 mm, mostly hyperechogenic (consisting probably of adipose tissue with little vascularization observed in Doppler color) and probably coming out of the left kidney, was reported. The right kidney was 108 mm long, with no urinary retention and no deposits. The diagnostics were extended by computer tomography (CT) angiography of the abdomen with contrast, in which the following was stated: numerous AMLs in the left kidney, the biggest coming out from its lower part and affecting the whole paranephric space and going down to the level of iliac fossa with dimensions of about 226 × 95 × 104 mm. Except for this the other intra-abdominal organs revealed no abnormalities (Figures 1, 2). The patient qualified for surgical treatment. The whole kidney with the entire tumor was removed (Figure 3 and Figure 4) by performing a median transperitoneal incision. Due to the risk of serious bleeding, the priority was to reach the renal vessels. The procedure was performed without any complications with the loss of 100 ml of blood. Further recovery proceeded without any complications. Histopathological examination confirmed the diagnosis of AML.
Figure 1

Computer tomography (CT) angiography - visible tumor and pathological vessel.

Figure 2

A different scan with a visible tumor.

Figure 3

A post-surgical specimen with a visible fragment of ureter and healthy renal parenchyma.

Figure 4

A post-surgical specimen with a visible fragment of healthy renal parenchyma.

Computer tomography (CT) angiography - visible tumor and pathological vessel. A different scan with a visible tumor. A post-surgical specimen with a visible fragment of ureter and healthy renal parenchyma. A post-surgical specimen with a visible fragment of healthy renal parenchyma.

Discussion

AML is one of the rarely occurring solid tumors of the kidney (2 to 6%). Most frequently they are diagnosed by chance during imaging examinations and they do not reach large sizes. They occur multifocally in about 1/3 and bilaterally in about 15% of all cases. They coexist with tuberous sclerosis (Bourneville-Pringle disease) with a frequency of about 20%. In such patients AML is diagnosed in 40 to 80% with a 2 to 3% risk of coexistence of renal cell carcinoma (RCC). AML has a mild nature and it does not produce metastases. Most frequently it proceeds asymptomatically. It may induce hematuria and uncharacteristic pain [1-3]. The most serious and dangerous complication for health from AML is spontaneous bleeding into the retroperitoneal space from pathological vessels, referred to as Wünderlich syndrome [7]. Diagnosis is based mainly on imaging examinations: USG and CT (presence of adipose tissue within the tumor mass of density of 10 Hounsfield units is a characteristic feature), magnetic resonance imaging (MRI), angiography. Tumors larger than 4 cm are usually symptomatic and these are the tumors which require control every six months [8]. The incidence of AML larger than 10 cm in individuals without a diagnosis of tuberous sclerosis is extremely rare. The commonly applied methods of treatment include: cryoablation, embolization, tumorectomy, partial resection of the kidney, or nephrectomy. The choice and scope of treatment is determined by: tumor size, its vascularization, symptoms and comorbidities [9]. Septo-optic dysplasia (de Morsier syndrome) is a syndrome of congenital defects which occurs at a frequency of 1:50,000 and which consists of: optic nerve hypoplasia, hypopituitarism, and agenesis of the septum pellucidum. Its etiology is multivariate and still not fully known. Recent reports claim a possible role of the HESX1 gene which is responsible for the development of the pituitary and central parts of the brain. Boys fall ill from this syndrome just as often as girls [10]. So far, an increased frequency of coexistence of renal carcinomas, including AML, has not been described. Herein, we have presented the first case of a large AML in a patient with de Morsier syndrome.

Conclusions

We have presented an extremely rare case of the coexistence of congenital defects in the form of septo-optic dysplasia associated with a giant renal AML. The patient required a precise diagnostic work-up and radical surgical treatment.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
  9 in total

1.  Wünderlich's syndrome: causes, diagnosis and radiological management.

Authors:  G Albi; L del Campo; D Tagarro
Journal:  Clin Radiol       Date:  2002-09       Impact factor: 2.350

2.  [Studies on malformation of cranio-encephalic sutures. III. Agenesis of the septum lucidum with malformation of the optic tract].

Authors:  G DE MORSIER
Journal:  Schweiz Arch Neurol Psychiatr       Date:  1956

3.  Septo-optic dysplasia complex: a heterogeneous malformation syndrome.

Authors:  Agata Polizzi; Piero Pavone; Paola Iannetti; Luigi Manfré; Martino Ruggieri
Journal:  Pediatr Neurol       Date:  2006-01       Impact factor: 3.372

Review 4.  The tuberous sclerosis complex and its highly variable manifestations.

Authors:  Thomas S Lendvay; Fray F Marshall
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

5.  Angiomyolipoma: clinical metamorphosis and concepts for management.

Authors:  M L Blute; R S Malek; J W Segura
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

Review 6.  The management of renal angiomyolipoma.

Authors:  J E Oesterling; E K Fishman; S M Goldman; F F Marshall
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

7.  The natural history of renal angiomyolipoma.

Authors:  M S Steiner; S M Goldman; E K Fishman; F F Marshall
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

8.  Renal angiomyolipoma: optimal treatment based on size and symptoms.

Authors:  M Dickinson; H Ruckle; M Beaghler; H R Hadley
Journal:  Clin Nephrol       Date:  1998-05       Impact factor: 0.975

Review 9.  Genetics of septo-optic dysplasia.

Authors:  Daniel Kelberman; Mehul Tulsidas Dattani
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

  9 in total
  3 in total

1.  Successful robot-assisted partial nephrectomy for giant renal hilum angiomyolipoma through the retroperitoneal approach: A case report.

Authors:  Shu-Hang Luo; Qin-Song Zeng; Jun-Xing Chen; Bin Huang; Zong-Ren Wang; Wen-Ji Li; Yun Yang; Ling-Wu Chen
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

2.  Role of MnSOD in propofol protection of human umbilical vein endothelial cells injured by heat stress.

Authors:  F Wu; X J Dong; H Q Zhang; L Li; Q L Xu; Z F Liu; Z T Gu; L Su
Journal:  J Anesth       Date:  2016-01-13       Impact factor: 2.078

3.  Familial genetic tuberous sclerosis complex associated with bilateral giant renal angiomyolipoma: A case report.

Authors:  Lina Wang; Dawei Ni; Lin Zhong; Jianbo Wang
Journal:  Oncol Lett       Date:  2017-10-10       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.